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Introduction: The development of an appropriate procedure for lentiviral gene transduction into keratinocyte stem
cells is crucial for stem cell biology and regenerative medicine for genetic disorders of the skin. However, there is
little information available on the efficiency of lentiviral transduction into human keratinocyte stem/progenitor cells
and the effects of gene transduction procedures on growth potential of the stem cells by systematic assessment.
Methods: In this study, we explored the conditions for efficient expansion of human keratinocyte stem/progenitor
cells carrying a transgene with a lentiviral vector, by using the culture of keratinocytes on a feeder layer of 3 T3
mouse fibroblasts. The gene transduction and expansion of keratinocytes carrying a transgene were analyzed by
Western blotting, quantitative PCR, and flow cytometry.
Results: Polybrene (hexadiamine bromide) markedly enhanced the efficiency of lentiviral gene transduction, but
negatively affected the maintenance of the keratinocyte stem/progenitor cells at a concentration higher than 5 μg/ml.
Rho-assiciated kinase (ROCK) inhibitor Y-27632, a small molecule which enhanced keratinocyte proliferation,
significantly interfered with the lentiviral transduction into cultured human keratinocytes. However, a suitable
combination of polybrene and Y-27632 effectively expanded keratinocytes carrying a transgene.
Conclusions: This study provides information for effective expansion of cultured human keratinocyte stem/progenitor
cells carrying a transgene. This point is particularly significant for the application of genetically modified keratinocyte
stem/progenitor stem cells in regenerative medicine.Introduction
Recombinant retroviruses enable a transgene to perma-
nently integrate into the genome of a target cell, and are
widely used as a vector in gene therapy [1,2]. Efficient
and safe gene transduction into stem cells with viral vec-
tors is indispensable for successful regenerative medi-
cine, including the generation of genetically modified
tissue stem cells and induced pluripotent stem (iPS) cells
derived from patients affected by genetic disorders [3,4].
Transduction and silencing of genes with viral vectors
are also essential for analyzing stem cell function during
development, homeostasis and tumorigenesis. Thus, the* Correspondence: nanba.daisuke.mk@ehime-u.ac.jp
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reproduction in any medium, provided the ordevelopment of highly efficient and less-cytotoxic viral
gene transduction into stem cells is crucial for advances
in stem cell-based regenerative medicine and stem cell
biology.
Human skin contains keratinocyte stem cells that are
clonogenic when cultivated on a feeder layer of mouse
3 T3 fibroblasts, and show significant proliferative ca-
pacity in culture [5]. Ex vivo maintenance and expansion
of human keratinocyte stem cells have achieved the au-
tologous transplantation of confluent sheets of cultured
keratinocytes onto patients with extensive burns [6]. The
culture of keratinocyte stem cells has also enabled a
gene therapy for a genetic disorder of the skin. De Luca
and his colleagues [7] isolated epidermal keratinocyte
stem cells from a patient who carries a null allele and a
single point mutation in the LAMB3 gene encoding la-
minin beta 3 subunit, and thus is affected by junctional
epidermolysis bullosa. They transduced the full-lengthLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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retroviral vector, and prepared genetically corrected cul-
tured epidermal grafts. The grafts were engrafted and
remained stable for at least one year in the absence of
blisters, infections, inflammations or immune response.
Thus, gene transduction into cultured keratinocyte stem
cells assures the healing or alleviation of inherent genetic
disorders of the skin.
Polybrene (hexadimethrine bromide), a cationic poly-
mer, has been widely used to increase the efficiency of
retroviral transduction [8]. Cationic polymers, including
polybrene, enhance virus adsorption on the surface of
the cell by neutralizing the negative electrostatic repul-
sion between the cell surface and the virus particles
[9,10]. It has been reported that polybrene is utilized for
introduction of DNA into keratinocytes as a DNA
carrier [11,12], and that it also enhances gene transduc-
tion into keratinocytes with adenoviruses [13,14] and
retroviruses [15,16]. Besides polybrene, van den Bogaard
et al. have recently reported that Rho-associated kinase
(ROCK) inhibitor Y-27632 enhances lentiviral transduc-
tion into human keratinocytes [17]. However, there is lit-
tle information available on how polybrene and Y-27632
impact the efficiency of lentiviral transduction into hu-
man keratinocytes, keratinocyte proliferation and main-
tenance of the stem/progenitor cells. Here, we provide
information for an efficient and less-cytotoxic gene
transduction with a lentiviral vector into human epi-
dermal keratinocyte stem/progenitor cells cultured on




The culture of normal human epidermal keratinocytes
(strain no. 685389; KURABO, Osaka, Japan) isolated
from the foreskin of newborns was previously described
[18]. Briefly, frozen keratinocytes were thawed and cul-
tivated at clonal density on a feeder layer of mitomycin
C-treated 3 T3-J2 cells at 37°C as described [19,20]. The
medium was changed every four days. Cells were used
between passage 4 and 10. For determination of colony-
forming efficiency, 1 × 104 keratinocytes were cultured
as described above. Cultures were maintained for eight
days, and subsequently fixed in 3.7% buffered formalde-
hyde, and stained with 1% rhodamine B (Sigma-Aldrich,
St. Louis, MO, USA).
Preparation of lentiviral vector
A plasmid for lentiviral expression of enhanced green
fluorescent protein (EGFP) was generated by subcloning
the EGFP cDNA from pEGFP-N1 (Clontech, Palo Alto,
CA, USA) into the HIV-based self-inactivating lenti-
viral expression vector plasmid pCSII-CMV-MCS [21](RIKEN BioResource Center, Tsukuba, Japan). The EGFP
expression cassette under the control of CMV promoter
was introduced upstream of woodchuck hepatitis virus
posttranscriptional regulatory element in the transfer
plasmid pCSII-CMV-MCS. Lentiviral vector pseudotyped
with vesicular stomatitis virus glycoprotein was generated
by standard DNA transfection. HEK293T cells were trans-
fected with transfer, envelope and packaging plasmids
using lipofectamine LTX (Invitrogen, Carlsbad, CA, USA).
Viral vector particles were ultracentrifuged at 100,000 × g
for 1 hr, and resuspended in Dulbecco-modified Eagle’s
medium. To measure the functional titer, HEK293T cells
were seeded into a 24-well culture plate, transduced with
proper concentrations of viral vectors, and the functional
titer was analyzed by flow cytometry (FACS Calibur;
Becton Dickinson, Franklin Lakes, NJ, USA). The multi-
plicity of infection (MOI) of 1 was defined as a number of
functional lentiviral particles which was sufficient to intro-
duce a transgene into HEK293 cells with 100% efficiency.
Lentiviral infection
A total of 104 keratinocytes were seeded in a 12-well cell
culture plate with mitomycin C-treated 3 T3-J2 cells.
Keratinocytes were further incubated for four hours and
then infected by replacing the infection medium con-
taining lentiviral particles, polybrene and Y-27632 at
various concentrations. The infection medium was re-
moved and replaced by fresh medium after overnight in-
cubation. The treatment with Y-27632 continued until
Day 4 in culture. After seven days of cultivation, the ex-
pression level of the transgene was analyzed by Western
blotting and flow cytometry. Polybrene (hexadiamine
bromide) and Y-27632 were purchased from Sigma-
Aldrich and Wako (Osaka, Japan), respectively. The pro-
cedure of lentiviral infection and subsequent analysis of
gene transduction are described in Figure 1.
Western blotting
A total of 104 keratinocytes were seeded in a 12-well cell
culture plate with mitomycin C-treated 3 T3-J2 cells,
grown for seven days, and analyzed by Western blotting,
as previously described [18]. The luminescence signals
were detected by using ImageQuant LAS4010 (GE
Healthcare, Buckinghamshire, UK). Primary antibodies
used were as follows: rabbit polyclonal antibody to GFP
(#598; 1:1,000; Medical & Biological Laboratories, Nagoya,
Japan), and mouse monoclonal antibody to α-tubulin
(#T6199; 1:5,000; Sigma-Aldrich). Secondary antibodies
were horseradish peroxidase (HRP)-conjugated goat anti-
mouse and rabbit IgG (#115-055-174 and #211-032-171;
1:5,000; Jackson ImmunoResearch, West Grove, PA,
USA). Relative density of EGFP bands was measured with
Volocity (PerkinElmer, Branchburg, NJ, USA) and nor-
malized with density of α-tubulin bands. The values
Figure 1 The flowchart of lentiviral transduction and analysis of
gene transduction. The procedure of lentiviral transduction into
human keratinocyte stem/progenitor cells on a feeder layer of 3 T3
mouse fibroblasts, and subsequent analysis of gene transduction.
See also Methods.
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three independent experiments.Cell proliferation assay
A total of 104 keratinocytes were seeded in a 12-well cell
culture plate with mitomycin C-treated 3 T3-J2 cells.
After seven days of cultivation, keratinocytes were tryp-
sinized and stained with 0.4% Trypan blue (Invitrogen)
to identify dead cells. Then, the number of cells was coun-
ted with a Countess™ automated cell counter (Invitrogen),
which could eliminate the dead cells and large mitomycin
C-treated 3 T3-J2 fibroblasts with irregular shape. The
values (means ± SD) were determined based on results
from three independent experiments.Immunofluorescence microscopy
A total of 2 × 103 keratinocytes were seeded at clonal
density in a 35-mm cell culture dish with mitomycin
C-treated 3 T3-J2 cells, grown for six days, and ana-
lyzed by immunofluorescence microscopy, as previ-
ously described [18]. Rat monoclonal antibody to α6
integrin (clone GoH3; 1:200; Becton Dickinson), and
mouse monoclonal antibody to p63 (clone 4A4; 1:500;
Millipore, Bedford, MA, USA) and involucrin (clone
SY5; 1:1,000; Abcam, Cambridge, UK) were used as
primary antibodies. Cy3-conjugated goat anti-rat IgG
and anti-mouse IgG (#112-165-167 and #715-025-140;
1:500; Jackson ImmunoResearch) were used as secon-
dary antibodies.Flow cytometry
A total of 2 × 105 keratinocytes were seeded in a 60-mm
cell culture dish with mitomycin C-treated 3 T3-J2 cells,
transduced EGFP cDNA with lentivirus vector in pres-
ence or absence of Y-27632, and grown for seven days.
Trypsinized and resuspended keratinocytes were incu-
bated with mouse monoclonal antibody against α6 integ-
rin (clone 17D11; 1:20; a gift from Dr. Hirako, Nagoya
University, Nagoya, Japan) for 1 hr on ice. Keratinocytes
were incubated with phycoerythrin (PE)-conjugated goat
polyclonal antibody against mouse IgG (sc-3738; 1:250;
Santa Cruz Biotechnology, Santa Cruz, CA, USA) for
1 hr on ice. After three washes with Hank’s Balanced salt
solution containing calcium and magnesium (HBSS (+)),
the cells were then resuspended in HBSS (+) and ana-
lyzed by using the FACSCan flow cytometer (Becton
Dickinson).
Calculation of EGFP-positive keratinocytes and 3 T3
feeder cells
The percentages of EGFP-positive keratinocytes and
3 T3 feeder cells were calculated by the following
equations: EGFP-positive keratinocytes (%) = (% of EGFP-
positive and ITGA6-positive cells)/(% of EGFP-positive
and ITGA6-positive cells +% of EGFP-negative and
ITGA6-positive cells) × 100, and EGFP-positive 3 T3
feeder cells (%) = (% of EGFP-positive and ITGA6-
negative cells)/(% of EGFP-positive and ITGA6-negative
cells +% of EGFP-negative and ITGA6-negative cells) ×
100. The values (means ± SD) were determined based on
results from three independent experiments.
Quantitative PCR
A total of 2 × 105 keratinocytes were seeded in a 60 mm
cell culture dish with mitomycin C-treated 3 T3-J2 cells,
transduced EGFP cDNA with lentivirus vector in the
presence or absence of Y-27632, and grown for seven
days. Genomic DNA was extracted from keratinocytes
and 3 T3-J2 cells with lysis buffer consisting of 50 mM
Tris–HCl (pH 8.0), 100 mM NaCl, 20 mM EDTA, 1%
SDS, and 5 units/mL of Proteinase K (Sigma-Aldrich).
The DNA (50 ng) was subjected to quantitative PCR
using Power SYBR Green PCR Master Mix Reagents and
a 7300 Real-Time PCR System (Applied Biosystems,
Foster City, CA, USA). Relative copy number of the
transgene was calculated based on the ΔΔCt method by
normalization using the Ct-value of the human or mouse
phosphoglycerate kinase (PGK) gene. The detection
primers used were as follows: 5′-GTGAACGGATCTA
CAAATGGCAG and 5′- GTCTGTTGCTATTATGTC
TACTA for the recombinant lentiviral vector, 5′- TGA
TTATTGGTGGTGGAATGGCTT and 5′-TGGAGGT
CAGCATCTATACTAAGA for the human PGK gene,
and 5′-TGCTAGACAAAGTCAATGAGATGA and 5′-
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PGK gene. The values (means ± SD) were determined
based on results from three independent experiments.
Results
Polybrene enhances transduction efficiency but reduces
growth potential of keratinocytes
To evaluate gene transduction with a lentiviral vector,
we prepared a lentiviral vector expressing EGFP underFigure 2 The effects of polybrene on gene transduction efficiency an
Western blotting of lysates from keratinocytes transduced with the enhanc
multiplicity of infection (MOI). The expression of α-tubulin was used as load
values (mean ± SD) were obtained from the density of bands normalized w
lysates from keratinocytes transduced with the EGFP-expressing lentivirus a
α-tubulin was used as loading control. Right panel shows relative expressio
density of bands normalized with α-tubulin bands. (C) Images of phase-con
EGFP-expressing lentivirus at MOI 1, and various concentrations of polybren
proliferation are shown. Keratinocytes (104 cells) were cultivated with variou
number of keratinocytes were counted after seven days of infection. (E) De
infected with lentiviral particles at MOI 1, and various concentrations of po
cultured without polybrene for eight days until the cultures were fixed and
B, and D were determined based on results from triplicate experiments.the control of the cytomegalovirus (CMV) promoter.
After four hours of seeding on a feeder layer of mitomy-
cin C-treated 3 T3 cells, keratinocytes were infected with
the EGFP-expressing virus at various MOI, and the ex-
pression of EGFP was analyzed by Western blotting after
seven days of culture (Figure 1). Increased expression
levels of EGFP correlated with the increase in the MOI
(Figure 2A). Less than 10% of keratinocytes expressed
EGFP at MOI 1 (Figure 2C), a condition in which almostd growth potential of keratinocytes. (A) The left panel shows
ed green fluorescent protein (EGFP)-expressing lentivirus at various
ing control. Right panel shows relative expression levels of EGFP. The
ith α-tubulin bands. (B) The left panel shows Western blotting of
t MOI 1, and various concentration of polybrene. The expression of
n levels of EGFP. The values (mean ± SD) were obtained from the
trast and EGFP expression in keratinocytes transduced with the
e. Bar, 100 μm. (D) The effects of polybrene on keratinocyte
s concentration of polybrene during lentivirus transduction, and the
termination of colony-forming efficiency (CFE) of keratinocytes
lybrene. After seven days of infection, 104 cells were passaged and
stained with rhodamine B. Bar, 10 mm. The values (means ± SD) in A,
Figure 3 Polybrene negatively impacts the proliferation and
maintenance of growth potential of human keratinocytes.
(A) The effects of polybrene on keratinocyte proliferation are shown.
Keratinocytes (2 × 105 cells) were seeded and treated with various
concentration of polybrene overnight, and then the number of
keratinocytes were counted after seven days of cultivation. The
values (means ± SD) were determined based on results in triplicate
experiments. (B) Determination of colony-forming efficiency (CFE) of
keratinocytes cultivated with various concentrations of polybrene is
shown. After seven days of cultivation with the condition described
above, 104 cells were passaged and cultured without polybrene
for eight days until the cultures were fixed and stained with
rhodamine B. Bar, 10 mm.
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fects of polybrene on lentiviral gene transduction at
MOI 1 into human epidermal keratinocytes. Polybrene
was added into the medium in which keratinocytes were
incubated overnight with lentiviral particles. The next
day, the medium containing polybrene and the lentivi-
ruses was removed and replaced with fresh medium.
Keratinocytes were further cultivated for six days, and
the expression of EGFP was analyzed by Western blot-
ting. As the concentration of polybrene increased, the
expression levels of EGFP also increased (Figure 2B, C).
An overnight treatment with polybrene for lentiviral
transduction, however, inhibited the proliferation of ke-
ratinocytes, even if keratinocytes were treated with only
2.5 μg/ml of polybrene (Figure 2D). We further investi-
gated the effect of polybrene on the growth potential of
keratinocytes. Keratinocytes were treated with polybrene
overnight for lentiviral transduction at MOI 1, and the
same number of keratinocytes (104 cells) was passaged
into a new 6-cm cell culture dish after seven days of cul-
ture. The keratinocytes were then maintained without
polybrene for eight days until the culture was fixed and
stained with rhodamine B. The results indicated that
transient treatment of keratinocytes with polybrene ne-
gatively affected the maintenance of growth potential of
human keratinocytes at a concentration higher than
5 μg/ml (Figure 2E). Collectively, the treatment of kerati-
nocytes with 2.5 μg/ml of polybrene could enhance len-
tiviral transduction efficiency significantly and maintain
their growth potential.
We next examined whether negative effects of poly-
brene on keratinocyte proliferation and growth potential
resulted from the toxicity of EGFP expression in trans-
duced keratinocytes. An overnight treatment with poly-
brene after seeding markedly inhibited the proliferation
of untransduced keratinocytes (Figure 3A), as shown in
transduced keratinocytes (Figure 2D). Furthermore, as
the concentration of polybrene increased, the colony-
forming efficiency (CFE) decreased (Figure 3B). These
data confirmed that polybrene itself negatively impacted
the proliferation and maintenance of growth potential of
human keratinocytes regardless of the EGFP expression.
Clonal expansion of keratinocyte stem/progenitor cells
expressing a transgene
Keratinocytes were seeded at clonal density, and trans-
duced with the EGFP-expressing lentivirus. In a condition
in which lentiviruses were infected into keratinocytes at
MOI 1 in the presence of 2.5 μg/ml of polybrene, progres-
sively growing colonies expressed EGFP in almost all cells
(Figure 4A). Keratinocytes could be identified as α6 integ-
rin (ITGA6)-expressing cells [22] (Figure 4B). These gro-
wing colonies are formed by keratinocyte stem/progenitor
cells [18]. We confirmed that EGFP-expressing growingcolonies expressed p63, a transcriptional factor that is ex-
pressed in keratinocyte stem cells [23], and is essen-
tial for significant growth capacity of keratinocytes [24]
(Figure 4C). EGFP-expressing growing colonies also pos-
sessed the ability to stratify and express a terminal diffe-
rentiation marker, involucrin (INV) [25] (Figure 4D). The
expressions of these marker proteins in the colony derived
from EGFP-expressing keratinocyte stem/progenitor cells
were completely identical to those in progressively gro-
wing colonies formed by untransduced keratinocyte stem/
progenitor cells (Figure 4E). We further confirmed the
long-term maintenance of EGFP expression in kerati-
nocytes after cloning of an EGFP-expressing keratino-
cyte colony (Figure 4F). These results indicated that
Figure 4 (See legend on next page.)
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Figure 4 The maintenance of self-renewing and terminal differentiation abilities in keratinocyte stem/progenitor cells expressing
EGFP. (A) Images of phase-contrast (left column) and enhanced green fluorescent protein (EGFP) expression (middle column) in a progressively
growing colony. The merged image (right column) shows clonal expansion of EGFP-expressing single keratinocytes. Keratinocytes (2 × 103 cells)
were seeded on mitomycin C-treated 3 T3 cells, and transduced with the EGFP-expressing lentiviral vector at multiplicity of infection (MOI) 1.
After six days of cultivation, the expression of EGFP and keratinocyte marker proteins were analyzed by immunofluorescence microscopy. (B-D)
The left column shows the expression of EGFP in growing colonies. The middle column shows the expression of ITGA6 (B), p63 (C), or involucrin
(INV) (D). DNA was also visualized with Hoechst 33258, and merged images (right column) show clonal expansion of EGFP-expressing single
keratinocytes. (E) The phase-contrast image and the expression of ITGA6, p63 and INV in progressively growing colonies derived from
untransduced keratinocyte stem/progenitor cells. Bars, 100 μm. (F) Long-term maintenance of EGFP expression in keratinocyte stem/progenitor
cells. The EGFP-expressing colony was isolated, trypsinized and expanded in a new culture dish. EGFP expression was maintained for at least
18 days after the lentivirus was transduced. Bars, 100 μm.
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could be maintained long-term in the presence of 2.5 μg/ml
of polybrene during lentiviral transduction.
Lower transduction efficiency of 3 T3 feeder cells
Lentiviral transduction enables a transgene to perma-
nently integrate into the genome of cells, even if the
cells do not proliferate [26]. However, the expression of
EGFP was mainly observed in keratinocyte colonies, but
not in the feeder cells, after seven days of transduction
as shown above (Figure 4A-D). The lower transduction
efficiency of 3 T3 feeder cells favors the generation and
transplantation of genetically engineered keratinocyte
stem/progenitor cells because transduction of a gene
that functions in keratinocytes into the 3 T3 feeder cells
might cause unexpected effects. To confirm the diffe-
rence in transduction efficiency between keratinocytes
and mitomycin C-treated 3 T3 fibroblasts precisely, we
evaluated the percentage of EGFP-expressing cells in
both cell types by flow cytometry. Keratinocytes were
recognized as ITGA6-positive cells in a mixed cell
population containing keratinocytes and fibroblasts
[27]. In a condition in which lentiviruses were infected
into keratinocytes at MOI 1 in the presence of 2.5 μg/ml
polybrene, 23.4 ± 2.62 (mean ± SD)% of ITGA6-positive
keratinocytes expressed EGFP (Figure 5A and See
Methods). However, the expression of EGFP was only de-
tectable in 1.64 ± 1.71 (mean ± SD)% of ITGA6-negative
3 T3 fibroblasts (Figure 5A and See Methods).
ROCK inhibitor interferes with lentiviral transduction into
keratinocytes
The addition of the ROCK inhibitor Y-27632 into the
culture medium results in the increased proliferation of
human keratinocytes [28-30]. The mechanism is still
unknown; however, it could have investigational and
medical applications. Therefore, we examined the effect
of Y-27632 on lentiviral transduction into human ke-
ratinocytes. Lentiviruses encoding EGFP cDNA were
infected with or without 10 μM Y-27632, and the effi-
ciency of gene transduction was analyzed by flow cyto-
metry after seven days of cultivation (Figure 5A-D). In acondition in which lentiviruses were infected into ke-
ratinocytes at MOI 1 in the presence of 2.5 μg/ml
polybrene, 23.4 ± 2.62% (mean ± SD) of ITGA6-positive
keratinocytes expressed EGFP (Figure 5A and See
Methods). However, only 8.51 ± 1.68% (mean ± SD) of
ITGA6-positive keratinocytes cultured in the presence of
10 μM Y-27632 expressed EGFP (Figure 5B and See
Methods). We further examined the integration of the
transgene gene into the genome of keratinocytes and
3 T3 fibroblasts, with or without Y-27632. Quantitative
PCR revealed that the integration of the exogenous
EGFP gene into keratinocytes was significantly interfered
with the treatment of Y-27632 (Figure 5E). This analysis
also confirmed that EGFP-expressing lentiviruses easily
infected into keratinocytes, compared to 3 T3 fibroblasts
(Figure 5A), as shown in Figure 3. Interestingly, Y-27632
inhibited lentiviral transduction into keratinocytes, but
not into a feeder layer of 3 T3 fibroblasts (Figure 5B, E).
We also counted the number of EGFP-positive cells in
the keratinocyte cultures two days after lentiviral trans-
duction with or without 10 μM Y-27632, and confirmed
that Y-27632 inhibited lentiviral transduction (Figure 5F).
This result indicated that the decreased ratio of EGFP-
expressing keratinocytes with Y-27632 after seven days
of cultivation was not mainly due to the increased ex-
pansion of untransduced keratinocytes with Y-27632.
A combination of polybrene and Y-27632 efficiently
expands keratinocytes carrying a transgene
We confirmed that Y-27632 increased colony-forming
efficiency and keratinocyte proliferation, even if used at
1.0 μM (Figure 6A). Finally, we explored the condition
in which keratinocytes carrying EGFP transgene were
expanded the most efficiently. EGFP-expressing lentivi-
ruses were infected into keratinocytes at MOI 1 in the
presence of 2.5 μg/ml polybrene and various concen-
trations of Y-27632. Keratinocytes were treated with
Y-27632 for four days after the first day of cultivation.
We evaluated the efficiency of gene transduction into
keratinocytes by flow cytometry after seven days of culti-
vation. Although the number of keratinocytes increased
(Figure 6B), the percentage of EGFP-positive keratinocytes
Figure 5 (See legend on next page.)
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Figure 5 The interference of a ROCK inhibitor with lentiviral gene transduction. (A-D) Flow cytometric analysis of keratinocyte culture on a
feeder layer of 3 T3 fibroblasts in the presence (B) and absence (A) of Rho-associated kinase (ROCK) inhibitor Y-27632. Keratinocytes (5 × 105 cells)
were seeded on mitomycin C-treated 3 T3 cells, and transduced with the enhanced green fluorescent protein (EGFP)-expressing lentiviral vector
at multiplicity of infections (MOI) 1, with and without 10 μM of Y-27632. After seven days of cultivation, the expression levels of EGFP and ITGA6
were analyzed by flow cytometry. ITGA6-positive and -negative cells were recognized as keratinocytes and 3 T3 fibroblasts, respectively.
Representative dot plot images of triplicate experiments in each experimental condition are shown. Numerical values indicate the percentage of
cells in each subpopulation. (C-D) Negative controls of flow cytometric analysis of keratinocyte culture on a feeder layer of 3 T3 fibroblasts shown
in Figure 3. Keratinocytes (5 × 105 cells) were seeded on mitomycin C-treated 3 T3 cells, grown for seven days, and analyzed by flow cytometry.
Flow cytometric analysis of the untransduced suspended keratinocytes and 3 T3 fibroblasts incubated with only PE-conjugated secondary
antibodies (C), or with PE-conjugated secondary antibodies after treatment with anti-ITGA6 antibodies (D). Numerical values indicate the
percentage of cells in each subpopulation. (E) Quantitative PCR analysis of relative copy number of EGFP transgene in keratinocytes and 3 T3
fibroblasts in the presence (□) and absence (■) of 10 μM of Y-27632. (F) The number of EGFP-positive cells in the keratinocyte cultures after two
days of lentiviral transduction in the presence and absence of 10 μM of Y-27632. P-value was calculated by Student’s t-test. n.s., not significant.
The values (means ± SD) in E and F were determined based on results from triplicate experiments.
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(Figure 6C and See Methods). However, the net num-
ber of EGFP-expressing keratinocytes increased as the
concentration of Y-27632 increased (Figure 6D), and still
did not reach a plateau by treatment with 20 μM of
Y-27632 (Figure 6D). The effects of higher concentra-
tions of Y-27632 should be tested. These data clearlyFigure 6 Efficient expansion of keratinocytes carrying EGFP with a co
colony-forming efficiency of keratinocytes treated with various concentratio
of 2.5 × 103 keratinocytes were seeded and cultured for 12 days until the c
Flow cytometric analysis of keratinocytes cultured on a feeder layer of 3 T3
(5 × 105 cells) were cultivated with various concentrations of Y-27632 durin
the keratinocyte cultures were analyzed after seven days of transduction. IT
3 T3 fibroblasts, respectively. The quantitative representation of the effects
into the keratinocytes (C) and the expansion of enhanced green fluorescen
were determined based on results from triplicate experiments.indicated that a combination of 2.5 μg/ml polybrene
and Y-27632 effectively expanded keratinocytes carry-
ing EGFP transgene.
Discussion
Gene transduction with lentiviral vectors has already been
used for basic and clinical studies of human keratinocytes.mbination of polybrene and Y-27632. (A) Determination of
ns of Y-27632 for four days, after the first day of cultivation. A total
ultures were fixed and stained with rhodamine B. Bar, 10 mm. (B-D)
fibroblasts with various concentrations of Y-27632. Keratinocytes
g lentivirus transduction at multiplicity of infections (MOI) 1, and then
GA6-positive and -negative cells were recognized as keratinocytes and
of Y-27632 on keratinocyte proliferation (B), transduction efficiency
t protein (EGFP)-expressing keratinocytes (D). The values (means ± SD)
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human keratinocyte stem/progenitor cells carrying a
transgene with lentiviral vector by using polybrene and
Y-27632. This work has three major findings concerning
lentiviral transduction into keratinocytes. First, polybrene
markedly enhances the efficiency of lentiviral gene trans-
duction, but reduces keratinocyte proliferation and ne-
gatively impacts the maintenance of keratinocyte stem/
progenitor cells at a concentration higher than 5 μg/ml.
Second, ROCK inhibitor Y-27632 significantly interferes
with the lentiviral transduction into cultured human kera-
tinocytes. Third, a suitable combination of polybrene and
Y-27632 can effectively expand keratinocytes carrying a
transgene.
Polybrene is widely used in viral gene transduction.
Polybrene has no cytotoxic activity at low concentra-
tions, but negatively affects the proliferation of corneal
keratinocytes at concentrations greater than 10 μg/ml
[31]. It also negatively impacts the proliferation of hu-
man mesenchymal stem cells, even if used at 1 μg/ml
[32]. It has been reported that treatment with 2 to
6 μg/ml of polybrene results in the highest efficiency of
gene transduction with adenoviruses in human epider-
mal keratinocytes [14]. In our experiments, 20 μg/ml of
polybrene was required to induce the highest expression
of transgene in lentiviral transduction. However, poly-
brene significantly reduced the proliferation of keratino-
cytes, even if used at low concentrations. Furthermore,
we demonstrated that polybrene negatively impacted the
maintenance of the keratinocyte stem/progenitor cells at
a concentration higher than 5 μg/ml. In serial culture,
keratinocyte stem cells progressively lose their prolifera-
tive capacity to become transient amplifying cells with
limited growth, a phenomenon termed clonal conversion
[33]. Clonal conversion is accelerated by stress, subop-
timal culture conditions, serial cultivation and age of
donor [33]. It is also governed by the balance of Rac1
and Akt signaling activity and actin filament orga-
nization [18]. As polybrene modulates the charge of the
cell surface, it might affect these intracellular signaling
pathways and actin network, and then increase the rate
of clonal conversion. Retroviral gene transfer into kerati-
nocytes is also enhanced by another polycationic poly-
mer, protamine sulfate [31] and by their cultivation on a
substrate of fibronectin [16]. The effects of these rea-
gents on transduction efficiency and clonal conversion
should be further investigated.
The process of retroviral infection involves the ab-
sorption of viral particles on the host plasma membrane,
the entry of the viral protein-RNA complexes into the
cytoplasm, the reverse transcription of viral RNA into
DNA and the intracellular trafficking and entry of viral
protein-DNA complexes into the nucleus, which is fol-
lowed by the integration of viral DNA into the hostgenome [26]. We have clearly demonstrated here that
the ROCK inhibitor Y-27632 interfered with the len-
tiviral transduction in human epidermal keratinocytes.
ROCK regulates both actin polymerization and phosphor-
ylation of myosin regulatory light chain [34]. Recently, it
has also been shown that ROCK regulates microtubule
dynamics through phosphorylation of the tubulin poly-
merization promoting protein 1 (TPPPA/p25) [35]. The
cytoskeleton, including actin filaments and microtubules
in the host cells, contributes to intracellular transport of
retroviral genomes from the cytoplasm into the nucleus
[36-38]. As further investigations should be required,
ROCK activity could be involved in intracellular traffic-
king of the retroviral genome.
Interestingly, van den Bogaard et al. have recently re-
ported that Y-27632 enhances lentiviral transduction
into human keratinocytes [17]. This report seems to be
contrary to our results. However, van den Bogaard et al.
have used high-passage adult keratinocytes for lentivirus
transduction and the generation of human skin equiva-
lents (HSEs), and then assessed the efficiency of lenti-
viral transduction into keratinocytes in HSEs, but not in
cultured keratinocytes. Human adult keratinocytes sig-
nificantly decrease their proliferative capacity by serial
cultivation and stress in culture, including gene transduc-
tion [33]. Therefore, the enhanced expansion of EGFP-
expressing adult keratinocytes in HSEs by Y-27632 might
be due to the fact that the expansion of Y-27632-treated
adult keratinocytes expressing EGFP is more efficient than
that of untreated EGFP-expressing adult keratinocytes
during the formation of HSEs.
van den Bogaard et al. has also reported high levels of
GFP expression in the differentiated layers of HSEs [17].
We also observed that EGFP was strongly expressed in
stratified and differentiating cells in the center of co-
lonies. These results suggest that CMV promoter activity
is enhanced in the stratified and differentiating kera-
tinocytes. Y-27632 inhibits keratinocyte differentiation
[28-30]. These observations alone suggest that Y-27632
inhibits EGFP expression under the control of the CMV
promoter, but not lentiviral transduction itself. However,
our quantitative PCR analysis has revealed that the inte-
gration of the exogenous EGFP gene into keratinocytes
significantly interfered with the treatment of Y-27632.
Consequently, reduced expression of EGFP after len-
tiviral transduction with Y-27632 might be, at least
partially, due to the inhibition of keratinocyte differenti-
ation and, therefore, CMV promoter activity by Y-27632,
as well as lower transduction efficiency by the treatment
with Y-27632.
We have demonstrated in this study that keratinocytes
gave rise to colonies derived from their stem/progenitor
cells carrying a transgene after lentiviral transduction
with lower concentration of polybrene. We have also
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ing EGFP transgene could maintain both self-renewing
and terminal differentiation abilities that are indispen-
sable for making a functional epidermal sheet ex vivo,
and permanent engraftment after transplantation [33,39].
These results indicate that a homologous clone of a kera-
tinocyte stem cell carrying a transgene can be isolated and
expanded massively for cell therapy for genetic disorders
of the skin [7,40].
Conclusions
A suitable combination of polybrene and Y-27632 effi-
ciently expands keratinocyte stem/progenitor cells car-
rying a transgene, although polybrene and Y-27632
negatively affect growth and lentiviral transduction of
human keratinocyte stem/progenitor cells, respectively.
This point is particularly significant for the application
of genetically modified keratinocyte stem/progenitor
stem cells in regenerative medicine.
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